Nonpharmacologic Strategies for Chronic Pain
(INSPIRE Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on non-drug strategies for managing pain, so it's possible you can continue your current medications, but you should confirm with the study team.
What data supports the effectiveness of the treatment Integrating Nonpharmacologic Strategies for Pain?
Is the treatment of nonpharmacologic strategies for chronic pain generally safe for humans?
The safety data for nonpharmacologic strategies for chronic pain is not well-documented, as many clinical trials do not adequately report adverse events (unwanted effects). However, these treatments are generally considered safe, though specific safety information is often incomplete or inconsistent.678910
How does the treatment Integrating Nonpharmacologic Strategies for Pain differ from other treatments for chronic pain?
This treatment is unique because it combines various non-drug approaches like relaxation, meditation, cognitive behavioral therapy, and exercise to manage chronic pain, focusing on improving quality of life and function rather than just reducing pain. It offers a holistic approach that addresses both physical and psychological aspects of pain, potentially reducing the need for pain medications.211121314
What is the purpose of this trial?
INSPIRE creates a trilingual mobile app and telehealth coaching program to promote non-pharmacologic strategies for pain management with Black, Chinese, and Latinx communities in the San Francisco Bay Area. Years 1-2 will develop the app and test it with a brief single arm pilot starting in Nov 2023. A full two arm randomized controlled trial (RCT) will being in early 2025 with changes in PEG scores as the primary outcome. Secondary outcomes include Helping to End Addiction Longterm (HEAL) common data elements.
Research Team
Jason Satterfield, PhD
Principal Investigator
University of California, San Francisco
Eligibility Criteria
This trial is for individuals from Black, Chinese, and Latinx communities in the San Francisco Bay Area who are experiencing chronic pain. Participants should be comfortable using a mobile app and telehealth coaching program.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pilot Testing
Development and testing of the trilingual mobile app and telehealth coaching program with a brief single arm pilot
Randomized Controlled Trial (RCT)
Full two arm RCT to evaluate changes in PEG scores and secondary outcomes
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Integrating Nonpharmacologic Strategies for Pain
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
University of California, Berkeley
Collaborator
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator